De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Omega Healthcare Investors Toekomstige groei
Future criteriumcontroles 1/6
De omzet van Omega Healthcare Investors zal naar verwachting dalen met 0.4% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 9.6% per jaar. De winst per aandeel zal naar verwachting groeien met 6.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.2% zijn.
Belangrijke informatie
9.5%
Groei van de winst
6.1%
Groei van de winst per aandeel
| Health Care REITs winstgroei | 31.0% |
| Inkomstengroei | -0.4% |
| Toekomstig rendement op eigen vermogen | 11.2% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 01 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Omega Healthcare Investors: High Dividend Yield And An Expected Massive Market
Sep 12Omega Healthcare: Attractive 7% Yield + 3 Other High Yield REITs
Aug 05Omega Healthcare Investors: 8.4% Yield And Selling Below Fair Price
Jun 14Omega Healthcare: You May Want To Wait For A Better Price
Jun 03Omega Healthcare: Clarity Regarding The Dividend Makes This 8.75% REIT Interesting
May 21Omega Healthcare: Better Options In The Healthcare Space For Dividend Investors
Apr 13Omega Healthcare Investors: How Safe Is The 9% Yield
Mar 28Omega Healthcare: Mr. Market Liked 2024 Guidance As The 8.55% Yield Remains Intact
Feb 26Omega Healthcare: This 9% Yield Is Not Safe
Jan 23Omega Healthcare Has Retraced As REITs Rallied Pushing The Yield To 8.71%
Dec 22Omega Healthcare Investors: Re-Adding This 8.4% Yielding Healthcare REIT On The Dip
Nov 29Omega Healthcare: High Yield 8+% Stock That Keeps On Paying
Nov 14Omega Healthcare: Time To Stop Adding This Passive Income Generator (Downgrade)
Oct 09Should You Buy Omega Healthcare Investors For Its 8.5% Yield?
Sep 08Omega Healthcare: The Power Of A Well-Covered High-Yield
Aug 15Omega Healthcare Has Been Heating Up, And The Dividend Keep Coming
Jul 18Omega Healthcare: Why The Stock Is A Hold
Jun 149.4%-Yielding Omega Healthcare: A Bargain With Upside Potential
May 25Omega Healthcare Investors FFO of $0.73 beats by $0.02, revenue of $144.85M misses by $25.77M
Feb 02Omega Healthcare Investors declares $0.67 dividend
Jan 26Omega Healthcare Investors sees EBITDA, funds available for distribution declining in Q1
Jan 09Omega Healthcare: Buy The Drop On This 10% Yield
Jan 01Omega Healthcare Q3: 8% Yielding Dividend Machine Provided Positive Guidance For Income Investors
Nov 14Omega Healthcare Investors declares $0.67 dividend
Oct 219%-Yielding Omega Healthcare Is Too Good To Pass Up
Oct 14Realty Income Shares Have Gone Nowhere For 6 Plus Years
Sep 28Omega Healthcare: Financial Strength Of Tenants Improved And Aging Demographics Are Positive
Sep 13Omega Healthcare: 8.2% Yield, Good Coverage, Low Valuation
Aug 24Omega Healthcare Q2 And Our Patience Test
Aug 11What's in store for Omega Healthcare Investors Q2 Earnings?
Jul 29Omega Healthcare Investors declares $0.67 dividend
Jul 21Omega Healthcare Investors: Mostly Medicaid Long-Term Care
Jul 09Omega Healthcare Investors: A REIT For Income With 9% Yield And Improving Cash Flow
Jun 08Omega Healthcare: A Look Past COVID
May 24Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 939 | 453 | N/A | N/A | 7 |
| 12/31/2025 | 907 | 421 | N/A | N/A | 9 |
| 12/31/2024 | 847 | 379 | N/A | N/A | 9 |
| 6/30/2024 | 977 | 328 | 672 | 672 | N/A |
| 3/31/2024 | 975 | 274 | 658 | 658 | N/A |
| 12/31/2023 | 950 | 242 | 618 | 618 | N/A |
| 9/30/2023 | 855 | 233 | 606 | 606 | N/A |
| 6/30/2023 | 853 | 244 | 602 | 602 | N/A |
| 3/31/2023 | 847 | 273 | 605 | 605 | N/A |
| 12/31/2022 | 878 | 427 | 626 | 626 | N/A |
| 9/30/2022 | 983 | 415 | 629 | 629 | N/A |
| 6/30/2022 | 1,026 | 451 | 649 | 649 | N/A |
| 3/31/2022 | 1,038 | 446 | 678 | 678 | N/A |
| 12/31/2021 | 1,063 | 417 | 722 | 722 | N/A |
| 9/30/2021 | 1,077 | 445 | 763 | 763 | N/A |
| 6/30/2021 | 914 | 215 | 757 | 757 | N/A |
| 3/31/2021 | 913 | 229 | 745 | 745 | N/A |
| 12/31/2020 | 892 | 159 | 708 | 708 | N/A |
| 9/30/2020 | 875 | 157 | 659 | 659 | N/A |
| 6/30/2020 | 989 | 388 | 618 | 618 | N/A |
| 3/31/2020 | 958 | 361 | 583 | 583 | N/A |
| 12/31/2019 | 929 | 341 | 554 | 554 | N/A |
| 9/30/2019 | 902 | 344 | 557 | 557 | N/A |
| 6/30/2019 | 891 | 262 | 548 | 548 | N/A |
| 3/31/2019 | 885 | 267 | 557 | 557 | N/A |
| 12/31/2018 | 882 | 282 | 499 | 499 | N/A |
| 9/30/2018 | 883 | 282 | 499 | 499 | N/A |
| 6/30/2018 | 881 | 93 | 531 | 531 | N/A |
| 3/31/2018 | 897 | 80 | N/A | 518 | N/A |
| 12/31/2017 | 908 | 100 | N/A | 578 | N/A |
| 9/30/2017 | 922 | 162 | N/A | 595 | N/A |
| 6/30/2017 | 927 | 373 | N/A | 602 | N/A |
| 3/31/2017 | 920 | 415 | N/A | 610 | N/A |
| 12/31/2016 | 901 | 366 | N/A | 625 | N/A |
| 9/30/2016 | 877 | 303 | N/A | 598 | N/A |
| 6/30/2016 | 854 | 304 | N/A | 558 | N/A |
| 3/31/2016 | 823 | 237 | N/A | 488 | N/A |
| 12/31/2015 | 744 | 225 | N/A | 449 | N/A |
| 9/30/2015 | 664 | 221 | N/A | 401 | N/A |
| 6/30/2015 | 593 | 203 | N/A | 364 | N/A |
| 3/31/2015 | 517 | 209 | N/A | 363 | N/A |
| 12/31/2014 | 505 | 221 | N/A | 338 | N/A |
| 9/30/2014 | 485 | 212 | N/A | 339 | N/A |
| 6/30/2014 | 457 | 188 | N/A | 325 | N/A |
| 3/31/2014 | 438 | 190 | N/A | 300 | N/A |
| 12/31/2013 | 419 | 173 | N/A | 280 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei OHI ( 9.6% per jaar) ligt boven de spaarquote ( 2.5% ).
Winst versus markt: De winst van OHI ( 9.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.2% per jaar).
Hoge groeiwinsten: De winst van OHI zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van OHI zal naar verwachting de komende 3 jaar dalen ( -0.4% per jaar).
Hoge groei-inkomsten: De omzet van OHI zal naar verwachting de komende 3 jaar dalen ( -0.4% per jaar).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen OHI zal naar verwachting over 3 jaar laag zijn ( 11.2 %).